StartseiteMCPWorkbenchSkills
StartseiteWorkbenchBenachrichtigungenMein Bereich
llms.txt · MCP-AnleitungDatenschutz · Nutzungsbedingungen · Supportv1.8.3
  1. Startseite
  2. /Verbindung

Pipamperone

HCID 4830
Neue Reaktion
Drucken
GrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung
TeilstruktursucheÄhnliche Strukturen suchen

Grundinformationen

CAS
1893-33-0
Standard-SMILES
NC(=O)C1(N2CCCCC2)CCN(CCCC(=O)c2ccc(F)cc2)CC1
InChIKey
AXKPFOAXAHJUAG-UHFFFAOYSA-N
Summenformel
C21H30FN3O2
Durchschnittliche Molmasse
375,5 g/mol
Monoisotopische Masse
375,23220537

Überblick

Pipamperone is a member of the class of bipiperidines that is 1,4'-bipiperidine which is substituted at the 1' and 4' positions by 4-(p-fluorophenyl)-4-oxobutyl and carboxamide groups, respectively. A first generation antipsychotic, its properties are generally similar to those of haloperidol. It has a role as a serotonergic antagonist, a dopaminergic antagonist and a first generation antipsychotic. It is a monocarboxylic acid amide, an organofluorine compound, a member of bipiperidines, a tertiary amino compound and an aromatic ketone. It is a conjugate base of a pipamperone(2+).

Namen und Bezeichner

Bevorzugter Name
Pipamperone
IUPAC
1-[4-(4-fluorophenyl)-4-oxobutyl]-4-piperidin-1-ylpiperidine-4-carboxamide
Englischer Name
Pipamperone dihydrochloride approx. 99
Summenformel
C21H30FN3O2
Molmasse
375.48

Namen und Synonyme

Pipamperone1893-33-0FloropipamideDipiperonePipamperonaPipamperonumR 3345NSC-7591781'-(3-(p-Fluorobenzoyl)propyl)-(1,4'-bipiperidine)-4'-carboxamideR-3345p-Fluoro-gamma-(4-piperidino-4-carbamoylpiperidino)butyrophenone1-[4-(4-fluorophenyl)-4-oxobutyl]-4-piperidin-1-ylpiperidine-4-carboxamide
Weitere Namen anzeigen
FPAPiperonylD02622PropitanDipiperonDipiperalpiperonilMCN-JR-3345
5402501F0WDTXSID8048369CHEBI:78549(1,4'-Bipiperidine)-4'-carboxamide, 1'-(4-(4-fluorophenyl)-4-oxobutyl)-[1,4'-Bipiperidine]-4'-carboxamide, 1'-[4-(4-fluorophenyl)-4-oxobutyl]-1-(4-(4-fluorophenyl)-4-oxobutyl)-4-piperidin-1-ylpiperidine-4-carboxamideRefChem:863377DTXCID8028343

Datenbank-Bezeichner

CAS
1893-33-0
PubChem CID
4830
DTXSID
DTXSID8048369

Eigenschaften

Berechnete Struktureigenschaften

XLogP
2
Polarare Oberfläche (TPSA)
66,6 Ų
H-Brücken-Donoren
1
H-Brücken-Akzeptoren
5
Frei drehbare Bindungen
7
Schwere Atome
27
Formalladung
0
Komplexität
506

Experimentelle und physikochemische Eigenschaften

Drugs · 5 Einträge

Pharmaceuticals -> Nervous system -> Antipsychotics

Pharmaceuticals

Pharmaceuticals -> Used in Switzerland

Pharmaceuticals -> Listed in ZINC15

Pharmaceuticals -> Antipsychotics

LogP2.68
Solubilitysoluble in methanol
Human DrugsPharmaceuticals
Melting Point>254
Collision Cross Section · 3 Einträge

192.6 Ų [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

194.1 Ų [M+H]+ [CCS Type: TW; Method: Major Mix IMS/Tof Calibration Kit (Waters)]

191.8 Ų [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

Physikochemische Eigenschaften

Schmelzpunkt
126 °C · 126°C(lit.)
Siedepunkt
563.7 · 563.7±50.0 °C(Predicted)

Sicherheit und Regulatorisches

Sicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.

GHS-Klassifizierung

GHS Classification · 4 Einträge

Danger

H301 (75%): Toxic if swallowed [Danger Acute toxicity, oral]

P261, P264, P270, P271, P273, P280, P301+P316, P301+P317, P302+P352, P304+P340, P317, P319, P321, P330, P332+P317, P362+P364, P391, P403+P233, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 4 reports by companies from 3 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Gefahrenhinweise

Regulatory InformationREACH registered substance: (1,4'-Bipiperidine)-4'-carboxamide, 1'-(3-(p-fluorobenzoyl)propyl)- (EC: 606-172-9)
Hazard Classes and CategoriesAcute Tox. 3 (75%)

Sicherheitsdaten

wgk
1
ridadr
UN 2811 6.1/PG III
hs_code
2933.39.3100
RTECS-Nr.
DW1060000
risk_code
22
hazard_code
Xn
hazard_class
6.1
packing_group
III

Chemie und Industrie

Pharmakologische Informationen

ATC Code · 3 Einträge

N05AD05

N - Nervous system

QN - Nervous system

Pharmacodynamics · 1 Eintrag

Pipamperone is an antipsychotic medication that has sedative effects, which may be beneficial in the management of agitation and disordered sleep. Pipamperone, showing antidopaminergic and anti-serotonergic properties, has been noted for its anti- agitation effects and for its ability to normalize sleep rhythms in psychiatric patients. One study showed that pipamperone increased the expression of D4 (dopaminergic) receptors, explaining its helpfulness in decreasing positive psychotic symptoms, such as delusions and hallucinations.

Mechanism of Action · 1 Eintrag

Pipamperone binds mainly to 5-HT2A receptors, with a nearly equal affinity to D4 receptors and a moderate affinity for 5-HT2C, D2, D3, 1- and 2B-adrenoceptors. This drug is a selective 5-HT2A, D1 and D4 antagonist. Extrapyramidal adverse effects also appear to be limited in pipamperone treatment compared to traditional antipsychotic medications due to its high receptor selectivity. Pipamperone has a 15-fold higher affinity for D4 than D2 receptors. It has been suggested that D4 receptors may play a role in the modulation of GABAergic neuronal activity by dopamine.

Biological Half-Life17-26h
Metabolism/MetabolitesPipamperone is metabolised in the liver.
MeSH Pharmacological Classification · 2 Einträge

Drugs that bind to but do not activate serotonin receptors, thereby blocking the actions of serotonin or SEROTONIN RECEPTOR AGONISTS.

Agents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in SCHIZOPHRENIA; senile dementia; transient psychosis following surgery; or MYOCARDIAL INFARCTION; etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus.

Zugehörige Reaktionen

1
Reaktionsaufzeichnung erstellen
Reaktionsgleichung von HRID 2379707
HRID 2379707als Produkt

Notizen zur Verbindung

Auf dieser SeiteGrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung
ChEMBL
CHEMBL440294
ChEBI
CHEBI:78549
UNII
5402501F0W
EC Number
606-172-9
Nikkaji
J7.805K
Dichte
1.1017 · 1.1017 (estimate)
storage temp.
-20 °C · Store at -20°C
Löslichkeit
2 O: · H2O: ~50 mg/mL
Aggregatzustand
powder
pka
16.2 · 16.20±0.20(Predicted)
Farbe
white
Wasserlöslichkeit
81.7 mg/L · 81.7mg/L at 25℃
Merck
14 · 14,7455
LogP
2.42 · 2.42
EPA chemische Informationen
Pipamperone (1893-33-0)
Absorption, Distribution and ExcretionMainly via the kidneys

Verwendung und Herstellung

UsesUse (kg; approx.) in Germany (2009): >2500
Use ClassificationPharmaceuticals

Anwendungen

VerwendenAntipsychotic.

Vor- und nachgelagerte Produkte

Vorgelagerte Rohstoffe

SchwefelsureKaliumcyanid1-Benzyl-4-piperidonWasserstoffPiperidin-hydrochlorid4-Chlor-4'-fluorbutyrophenon
Ergänzende Hinweise · 1 Eintrag

DefinitionChEBI: A member of the class of bipiperidines that is 1,4'-bipiperidine which is substituted at the 1' and 4' positions by 4-(p-fluorophenyl)-4-oxobutyl and carboxamide groups, respectively. A first generation antipsychotic, its properties are gener lly similar to those of haloperidol.